AMGN Icon

$AMGN

$AMGN

Amgen

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The companys principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçets disease; Prolia to treat postmenopausal women with ...

Stocks
Non-U.S. Investor

Total Asset Value

$20,380

+5.37%from 30d ago

Net Asset Value

$337

Holders

74

+8.82%from 30d ago

Monthly Transfer Volume

$597.47K

+778.93%from 30d ago

Amgen Metrics

Tokenized Public Stocks

10 Total